Moreover, we discovered that ENO1, a glycolytic enzyme involved in the ninth step of glycolysis, was the downstream effector of melatonin and could be a predictive biomarker of BLCA. This evidence concerns the gene ENO1 and bladder transitional cell carcinoma.